Syngene International Limited (BOM:539268)
451.85
+14.25 (3.26%)
At close: Nov 20, 2026
Syngene International Market Cap
Syngene International has a market cap or net worth of 179.82 billion as of November 20, 2026. Its market cap has decreased by 28.85% in one year.
Market Cap
179.82B
Enterprise Value
179.60B
Revenue
35.22B
Global Rank
n/a
Country Rank
n/a
PE Ratio
97.36
ChartMarket Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 179.82B, an increase of 189.52%. That is a compound annual growth rate of 9.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 179.82B | -30.61% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.56T |
| Divi's Laboratories | 2.97T |
| Lenskart Solutions | 1.29T |
| Apollo Hospitals Enterprise | 1.26T |
| OneSource Specialty Pharma | 181.76B |
| Alivus Life Sciences | 178.02B |
| Molbio Diagnostics | 176.43B |
| Pfizer | 176.27B |